No protocol is universally "best." The right choice depends on your history with GLP-1 agonists, your GI sensitivity, your access to appropriate syringes, your willingness to manage reconstitution at lower concentrations, and your goals
The FDA stated it planned to restrict the use of GLP-1 ingredients, like semaglutide, in non-approved compounded drugs, which is what companies like Hims & Hers market as alternatives to the pricier, authorized treatments
In diabetes-related gastrointestinal complications Its metabolic regulatory properties could assist in improving abnormal gastrointestinal motility and dyspepsia, reducing symptoms such as nausea, vomiting, and constipation
Why do low blood sugar treatments feel like a burden